Jove
Visualize
Contact Us

Related Experiment Videos

Surgery: therapeutic indications.

P E Van Schil1

  • 1Department of Thoracic and Vascular Surgery, University Hospital of Antwerp, Wilrijkstraat 10, B-2650 Edegem (Antwerp), Belgium. paul.van.schil@uza.be

Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|July 14, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up<sup>☆</sup>.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

[Early-stage lung cancer: Is there still a role for surgery?]

Revue des maladies respiratoires·2020
Same author

Correction to: "Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up".

Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same author

Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2018
Same author

TNM-Classification for Lung Cancer: From the 7(th) to the 8(th) Edition.

Acta chirurgica Belgica·2016
Same author

Aortic Dissection Limited to Abdominal Aorta: an Underrecognized Entity?

Acta chirurgica Belgica·2015
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Surgical resection is the preferred treatment for early-stage non-small cell lung cancer (NSCLC), offering the best prognosis. Lobectomy is the primary surgical approach, with other procedures reserved for specific cases.

Area of Science:

  • Thoracic Surgery
  • Oncology

Background:

  • Surgical resection is the standard treatment for early-stage non-small cell lung cancer (NSCLC).
  • While not definitively proven superior in large trials, it offers the best long-term prognosis for resectable stages IA-IIIA when complete resection is achieved.

Purpose of the Study:

  • To outline the current surgical approaches for early-stage non-small cell lung cancer (NSCLC).
  • To discuss the indications and considerations for various surgical techniques in NSCLC treatment.

Main Methods:

  • Review of standard and extended surgical resections for non-small cell lung cancer (NSCLC).
  • Discussion of lung parenchyma-sparing procedures and en bloc excisions.
  • Consideration of surgical resection following induction therapy.

Related Experiment Videos

Main Results:

  • Lobectomy is the preferred surgical procedure for non-small cell lung cancer (NSCLC) when feasible.
  • Lesser resections (segmentectomy, wedge excision) are rarely indicated for primary NSCLC.
  • Pneumonectomy, while sometimes necessary, is associated with high mortality and morbidity and should be avoided if possible.

Conclusions:

  • Surgical resection is the cornerstone of treatment for early-stage non-small cell lung cancer (NSCLC).
  • Accurate pre-operative evaluation is crucial for determining the extent of resection.
  • Resection after induction therapy is feasible but increases complexity and risk.